Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 115

1.

Immune checkpoint inhibitors therapy in older patients (≥ 70 years) with metastatic melanoma: a multicentre study.

Cybulska-Stopa B, Ługowska I, Jagodzińska-Mucha P, Koseła-Paterczyk H, Kozak K, Klimczak A, Świtaj T, Ziobro M, Roman A, Rajczykowski M, Suwiński R, Niemiec M, Zemełka T, Falkowski S, Rutkowski P.

Postepy Dermatol Alergol. 2019 Oct;36(5):566-571. doi: 10.5114/ada.2018.79940. Epub 2019 Nov 12.

2.

Prognostic value of the pretreatment neutrophil-to-lymphocyte ratio in patients with advanced gastrointestinal stromal tumors treated with sunitinib after imatinib failure.

Sobczuk P, Teterycz P, Lugowska I, Klimczak A, Bylina E, Czarnecka AM, Kosela-Paterczyk H, Osuch C, Streb J, Rutkowski P.

Oncol Lett. 2019 Sep;18(3):3373-3380. doi: 10.3892/ol.2019.10622. Epub 2019 Jul 16.

3.

Similarities and differences between mesenchymal stem/progenitor cells derived from various human tissues.

Kozlowska U, Krawczenko A, Futoma K, Jurek T, Rorat M, Patrzalek D, Klimczak A.

World J Stem Cells. 2019 Jun 26;11(6):347-374. doi: 10.4252/wjsc.v11.i6.347.

4.

Diverse Activity of IL-17+ Cells in Chronic Skin and Mucosa Graft-Versus-Host Disease.

Klimczak A, Suchnicki K, Sedzimirska M, Lange A.

Arch Immunol Ther Exp (Warsz). 2019 Oct;67(5):311-323. doi: 10.1007/s00005-019-00549-2. Epub 2019 Jun 8.

5.

Immunological Characteristics and Properties of Glial Restricted Progenitors of Mice, Canine Primary Culture Suspensions, and Human QSV40 Immortalized Cell Lines for Prospective Therapies of Neurodegenerative Disorders.

Klimczak A, Kozłowska U, Sanford J, Walczak P, Małysz-Cymborska I, Kurpisz M.

Cell Transplant. 2019 Sep-Oct;28(9-10):1140-1154. doi: 10.1177/0963689719848355. Epub 2019 May 24.

6.

Pulse-Modulated Radio-Frequency Alternating-Current-Driven Atmospheric-Pressure Glow Discharge for Continuous-Flow Synthesis of Silver Nanoparticles and Evaluation of Their Cytotoxicity toward Human Melanoma Cells.

Dzimitrowicz A, Bielawska-Pohl A, diCenzo GC, Jamroz P, Macioszczyk J, Klimczak A, Pohl P.

Nanomaterials (Basel). 2018 Jun 2;8(6). pii: E398. doi: 10.3390/nano8060398.

7.

High baseline neutrophil-to-lymphocyte ratio predicts worse outcome in patients with metastatic BRAF-positive melanoma treated with BRAF and MEK inhibitors.

Teterycz P, Jagodzińska-Mucha P, Cybulska-Stopa B, Mariuk-Jarema A, Kozak K, Koseła-Paterczyk H, Czarnecka AM, Rajczykowski M, Dziura R, Galus Ł, Mackiewicz J, Świtaj T, Klimczak A, Falkowski S, Suwiński R, Ziobro M, Ługowska I, Rutkowski P.

Melanoma Res. 2018 Oct;28(5):435-441. doi: 10.1097/CMR.0000000000000461.

PMID:
29782381
8.

Blood neutrophil-to-lymphocyte ratio is associated with prognosis in advanced gastrointestinal stromal tumors treated with imatinib.

Rutkowski P, Teterycz P, Klimczak A, Bylina E, Szamotulska K, Lugowska I.

Tumori. 2018 Dec;104(6):415-422. doi: 10.1177/0300891618765543. Epub 2018 Apr 18.

PMID:
29714669
9.

Treatment outcomes in older patients with advanced gastrointestinal stromal tumor (GIST).

Rutkowski P, Bylina E, Lugowska I, Teterycz P, Klimczak A, Streb J, Czarnecka AM, Osuch C.

J Geriatr Oncol. 2018 Sep;9(5):520-525. doi: 10.1016/j.jgo.2018.03.009. Epub 2018 Mar 27.

PMID:
29602734
10.

Muscle Stem/Progenitor Cells and Mesenchymal Stem Cells of Bone Marrow Origin for Skeletal Muscle Regeneration in Muscular Dystrophies.

Klimczak A, Kozlowska U, Kurpisz M.

Arch Immunol Ther Exp (Warsz). 2018 Oct;66(5):341-354. doi: 10.1007/s00005-018-0509-7. Epub 2018 Mar 13. Review.

11.

Embryonal mitochondrial DNA: relationship to embryo quality and transfer outcomes.

Klimczak AM, Pacheco LE, Lewis KE, Massahi N, Richards JP, Kearns WG, Saad AF, Crochet JR.

J Assist Reprod Genet. 2018 May;35(5):871-877. doi: 10.1007/s10815-018-1147-z. Epub 2018 Mar 5.

12.

Recommendations and Choices for BRCA Mutation Carriers at Risk for Ovarian Cancer: A Complicated Decision.

Lewis KE, Lu KH, Klimczak AM, Mok SC.

Cancers (Basel). 2018 Feb 21;10(2). pii: E57. doi: 10.3390/cancers10020057. Review.

13.

The analysis of the long-term outcomes of sorafenib therapy in routine practice in imatinib and sunitinib resistant gastrointestinal stromal tumors (GIST).

Rutkowski P, Jagielska B, Andrzejuk J, Bylina E, Lugowska I, Switaj T, Kosela-Paterczyk H, Kozak K, Falkowski S, Klimczak A.

Contemp Oncol (Pozn). 2017;21(4):285-289. doi: 10.5114/wo.2017.72393. Epub 2017 Dec 30.

14.

Potential benefit of optimizing atrioventricular & interventricular delays in patients with cardiac resynchronization therapy.

Urbanek B, Kaczmarek K, Klimczak A, Ruta J, Chudzik M, Piestrzeniewicz K, Ptaszynski P, Wranicz JK.

Indian J Med Res. 2017 Jul;146(1):71-77. doi: 10.4103/ijmr.IJMR_1560_14.

15.

[The long-term treatment outcomes of adult osteosarcoma].

Ługowska I, Pieńkowski A, Szumera-Ciećkiewicz A, Koseła-Paterczyk H, Teterycz P, Głogowski M, Kozak K, Klimczak A, Falkowski S, Rutkowski P.

Pol Merkur Lekarski. 2017 Apr 21;42(250):158-164. Polish.

PMID:
28530214
16.

Long-term results of treatment of advanced dermatofibrosarcoma protuberans (DFSP) with imatinib mesylate - The impact of fibrosarcomatous transformation.

Rutkowski P, Klimczak A, Ługowska I, Jagielska B, Wągrodzki M, Dębiec-Rychter M, Pieńkowska-Grela B, Świtaj T.

Eur J Surg Oncol. 2017 Jun;43(6):1134-1141. doi: 10.1016/j.ejso.2017.03.011. Epub 2017 Mar 22.

PMID:
28365129
17.

Long-term results of therapy with sunitinib in metastatic alveolar soft part sarcoma.

Jagodzińska-Mucha P, Świtaj T, Kozak K, Koseła-Paterczyk H, Klimczak A, Ługowska I, Rogala P, Wągrodzki M, Falkowski S, Rutkowski P.

Tumori. 2017 May 12;103(3):231-235. doi: 10.5301/tj.5000617. Epub 2017 Mar 8.

PMID:
28291905
18.

Medicolegal Review: Essure Lawsuits and Legal Strategies Adverse to Gynecologists.

Klimczak AM, Snyder RR, Borahay MA, Phelps JY.

J Minim Invasive Gynecol. 2017 Jul - Aug;24(5):727-730. doi: 10.1016/j.jmig.2017.02.017. Epub 2017 Feb 27. Review.

PMID:
28254503
19.

Expression and activity of multidrug resistance proteins in mature endothelial cells and their precursors: A challenging correlation.

Krawczenko A, Bielawska-Pohl A, Wojtowicz K, Jura R, Paprocka M, Wojdat E, Kozłowska U, Klimczak A, Grillon C, Kieda C, Duś D.

PLoS One. 2017 Feb 17;12(2):e0172371. doi: 10.1371/journal.pone.0172371. eCollection 2017.

20.

Assessment of immunologic, proangiogenic and neurogenic properties of human peripheral nerve epineurium for potential clinical application.

Klimczak A, Siemionow M, Futoma K, Jundzill A, Patrzalek D.

Histol Histopathol. 2017 Nov;32(11):1197-1205. doi: 10.14670/HH-11-875. Epub 2017 Jan 25.

PMID:
28120327
22.

The reversed paradigm of chimerism induction: Donor conditioning with recipient-derived bone marrow cells as a novel approach for tolerance induction in vascularized composite allotransplantation.

Siemionow M, Rampazzo A, Gharb BB, Cwykiel J, Klimczak A, Madajka M, Nasir S, Bozkurt M.

Microsurgery. 2016 Nov;36(8):676-683. doi: 10.1002/micr.30041. Epub 2016 Mar 14.

PMID:
26990895
23.

Mesenchymal Stromal Cells and Tissue-Specific Progenitor Cells: Their Role in Tissue Homeostasis.

Klimczak A, Kozlowska U.

Stem Cells Int. 2016;2016:4285215. doi: 10.1155/2016/4285215. Epub 2015 Dec 28. Review.

24.

Immunomodulatory Effects of Different Cellular Therapies of Bone Marrow Origin on Chimerism Induction and Maintenance Across MHC Barriers in a Face Allotransplantation Model.

Hivelin M, Klimczak A, Cwykiel J, Sonmez E, Nasir S, Gatherwright J, Siemionow M.

Arch Immunol Ther Exp (Warsz). 2016 Aug;64(4):299-310. doi: 10.1007/s00005-015-0380-8. Epub 2015 Dec 26.

PMID:
26708158
25.

Consumption of sweetened beverages as a risk factor of colonization of oral cavity by fungi - eating habits of university students.

Lll KG, Klimczak A, Rachubiński P, Jagłowska A, Kwapiszewska A.

Ann Parasitol. 2015;61(3):175-82. doi: 10.17420/ap6103.04.

26.

Short-term ECG recordings for heart rate assessment in patients with chronic atrial fibrillation.

Chudzik M, Cygankiewicz I, Klimczak A, Lewek J, Bartczak K, Wranicz JK.

Arch Med Sci. 2014 Aug 29;10(4):676-83. doi: 10.5114/aoms.2014.44859.

27.

Colorectal cancer morbidity in Poland and Japan in the years 1999-2006 - a comparison.

Klimczak A, Miśkiewicz M, Mik M, Dziki A, Utada M, Kempińska-Mirosławska B.

Arch Med Sci. 2014 Jun 29;10(3):490-7. doi: 10.5114/aoms.2014.40486. Epub 2014 Jun 27.

28.

Colorectal cancer mortality in Poland - analysis of regional variation.

Klimczak A, Kempińska-Mirosławska B, Mik M, Dziki L, Dziki A.

Arch Med Sci. 2014 Feb 24;10(1):63-7. doi: 10.5114/aoms.2012.28596. Epub 2012 May 13.

29.

Donor lymphocyte infusions to leukemic bone lesions are therapeutically effective in a Ph+ ALL patient with post-HSCT relapse.

Lange A, Dlubek D, Zdziarski R, Chodorowska A, Mordak-Domagala M, Klimczak A, Lange J, Jaskula E.

J Immunotoxicol. 2014 Oct;11(4):347-52. doi: 10.3109/1547691X.2014.893042. Epub 2014 Mar 10.

PMID:
24611731
30.

Influence of atrioventricular optimization on hemodynamic parameters and quality of life in patients with dual chamber pacemaker with ventricular lead in right ventricular outflow tract.

Klimczak A, Budzikowski AS, Rosiak M, Zielińska M, Urbanek B, Bartczak K, Chudzik M, Wranicz JK.

Ann Noninvasive Electrocardiol. 2014 Sep;19(5):471-6. doi: 10.1111/anec.12147. Epub 2014 Mar 6.

PMID:
24597906
31.

Ambulatory Holter monitoring in asymptomatic patients with DDD pacemakers - do we need ACC/AHA Guidelines revision?

Chudzik M, Klimczak A, Wranicz JK.

Arch Med Sci. 2013 Oct 31;9(5):815-20. doi: 10.5114/aoms.2013.38675. Epub 2013 Nov 5.

32.

A four-year pathology review of the near total face transplant.

Bergfeld W, Klimczak A, Stratton JS, Siemionow MZ.

Am J Transplant. 2013 Oct;13(10):2750-64. doi: 10.1111/ajt.12379. Epub 2013 Aug 6.

33.

Whether noninvasive optimization of AV and VV delays improves the response to cardiac resynchronization therapy.

Urbanek B, Chudzik M, Klimczak A, Rosiak M, Lewek J, Wranicz JK.

Cardiol J. 2013;20(4):411-7. doi: 10.5603/CJ.2013.0100.

34.

Chimerism-based experimental models for tolerance induction in vascularized composite allografts: Cleveland clinic research experience.

Siemionow M, Klimczak A.

Clin Dev Immunol. 2013;2013:831410. doi: 10.1155/2013/831410. Epub 2013 Mar 14.

35.

Effective treatment of recurrent, advanced dermatofibrosarcoma protuberans by electrochemotherapy.

Wiater K, Zdzienicki M, Morysiński T, Koseła H, Klimczak A, Obrębski M, Ptaszyński K, Rutkowski P.

Eur J Dermatol. 2013 Apr 1;23(2):260-1. doi: 10.1684/ejd.2013.1992. No abstract available.

PMID:
23567663
36.

Evolution of the mechanical suture.

Klimczak A, Mirosławska-Kempińska B, Mik M, Dziki A.

Pol Przegl Chir. 2013 Jan;85(1):44-6. doi: 10.2478/pjs-2013-0008. No abstract available.

PMID:
23509202
37.

Pre- and postischemic pulsed acoustic cellular expression conditioning modulates expression of inflammation factors in cremaster ischemia/reperfusion injury model.

Cwykiel JM, Klimczak A, Krokowicz L, Siemionow M.

Microsurgery. 2013 Feb;33(2):134-40. doi: 10.1002/micr.22048. Epub 2012 Nov 14.

PMID:
23152008
38.

Th17 mediated alloreactivity is facilitated by the pre-transplant microbial burden of the recipient.

Klimczak A, Lange A.

Bone Marrow Res. 2012;2012:960280. doi: 10.1155/2012/960280. Epub 2012 Oct 9.

39.

Composite osseomusculocutaneous sternum, ribs, thymus, pectoralis muscles, and skin allotransplantation model of bone marrow transplantation.

Bozkurt M, Klimczak A, Nasir S, Zor F, Krokowicz L, Siemionow M.

Microsurgery. 2013 Jan;33(1):43-50. doi: 10.1002/micr.22023. Epub 2012 Jul 23.

PMID:
22821819
40.

The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study.

Rutkowski P, Bylina E, Klimczak A, Switaj T, Falkowski S, Kroc J, Lugowska I, Brzeskwiniewicz M, Melerowicz W, Osuch C, Mierzejewska E, Wasielewski K, Woźniak A, Grzesiakowska U, Nowecki ZI, Siedlecki JA, Limon J.

BMC Cancer. 2012 Mar 22;12:107. doi: 10.1186/1471-2407-12-107.

41.

Photoinduced electron transfer across a molecular wall: coumarin dyes as donors and methyl viologen and TiO2 as acceptors.

Porel M, Klimczak A, Freitag M, Galoppini E, Ramamurthy V.

Langmuir. 2012 Feb 21;28(7):3355-9. doi: 10.1021/la300053r. Epub 2012 Feb 7.

PMID:
22303867
42.

Incidence of colorectal cancer in Poland in 1999-2008.

Klimczak A, Kempińska-Mirosławska B, Mik M, Dziki L, Dziki A.

Arch Med Sci. 2011 Aug;7(4):673-8. doi: 10.5114/aoms.2011.24138. Epub 2011 Sep 2.

43.

Manual stitching: the past and the present.

Klimczak A, Mirosławska-Kempińska B, Biegańska-Płonka M, Mik M, Dziki A.

Pol Przegl Chir. 2011 Sep;83(9):527-30. doi: 10.2478/v10035-011-0083-8. No abstract available.

PMID:
22166744
44.

Pulsed acoustic cellular expression as a protective therapy against I/R injury in a cremaster muscle flap model.

Krokowicz L, Klimczak A, Cwykiel J, Mielniczuk M, Grykien C, Siemionow M.

Microvasc Res. 2012 Mar;83(2):213-22. doi: 10.1016/j.mvr.2011.11.005. Epub 2011 Dec 6.

PMID:
22155420
45.

Human TH17 cells are long-lived effector memory cells.

Kryczek I, Zhao E, Liu Y, Wang Y, Vatan L, Szeliga W, Moyer J, Klimczak A, Lange A, Zou W.

Sci Transl Med. 2011 Oct 12;3(104):104ra100. doi: 10.1126/scitranslmed.3002949.

46.

[Genes responsible for etiopathogenesis in esophageal squamous cell carcinoma].

Klimczak A, Bitner J, Szemraj J.

Postepy Biochem. 2011;57(1):33-40. Review. Polish.

PMID:
21735818
47.

Peripheral nerve defect repair with epineural tubes supported with bone marrow stromal cells: a preliminary report.

Siemionow M, Duggan W, Brzezicki G, Klimczak A, Grykien C, Gatherwright J, Nair D.

Ann Plast Surg. 2011 Jul;67(1):73-84. doi: 10.1097/SAP.0b013e318223c2db.

PMID:
21629045
48.

The patterns of MHC association in aplastic and non-aplastic paroxysmal nocturnal hemoglobinuria.

Nowak J, Mika-Witkowska R, Mendek-Czajkowska E, Rogatko-Koroś M, Graczyk-Pol E, Pyl H, Klimczak A, Wójcik M, Prochorec-Sobieszek M, Maryniak R, Zupańska B.

Arch Immunol Ther Exp (Warsz). 2011 Jun;59(3):231-8. doi: 10.1007/s00005-011-0125-2. Epub 2011 Mar 27.

PMID:
21442308
49.

Chimerism in hand transplantation.

Szajerka T, Klimczak A, Jablecki J.

Ann Transplant. 2011 Jan-Mar;16(1):83-9. Review.

PMID:
21436781
50.

Association of HLA haplotypes with paroxysmal nocturnal hemoglobinuria.

Nowak J, Mika-Witkowska R, Mendek-Czajkowska E, Rogatko-Koros M, Graczyk-Pol E, Pyl H, Klimczak A, Wojcik M, Nowak EA, Dlugokecka A, Prochorec M, Zupanska B.

Transplant Proc. 2010 Oct;42(8):3266-70. doi: 10.1016/j.transproceed.2010.07.030.

PMID:
20970669

Supplemental Content

Loading ...
Support Center